About the Authors
- Ingo Flamme
-
* E-mail: ingo.flamme@bayer.com
Affiliation Cardiology/Hematology, Acute Care Research, Global Drug Discovery, Bayer Pharma AG, Wuppertal, Germany
- Felix Oehme
-
Affiliation Biotech Development, Global Biologics, Bayer Pharma AG, Wuppertal, Germany
- Peter Ellinghaus
-
Affiliation Clinical Science, Global Biomarkers, Bayer Pharma AG, Wuppertal, Germany
- Mario Jeske
-
Affiliation Global Chemical Product Development, Bayer Pharma AG, Wuppertal, Germany
- Jörg Keldenich
-
Affiliation Drug Metabolism and Pharmacokinetics, Global Early Development, Bayer Pharma AG, Wuppertal, Germany
- Uwe Thuss
-
Affiliation Drug Metabolism and Pharmacokinetics, Global Early Development, Bayer Pharma AG, Wuppertal, Germany
Competing Interests
Dr. Flamme has read the journal’s policy and the authors of this manuscript have the following competing interests: All the authors are employees of Bayer Pharma AG, the funding organization for this study. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: IF FO PE MJ JK UT. Performed the experiments: IF FO PE JK UT. Analyzed the data: IF FO PE MJ JK UT. Contributed reagents/materials/analysis tools: FO MJ. Contributed to the writing of the manuscript: IF FO PE MJ JK UT.